Damé Medarski’s Post

Top o' the Mornin' to Ya! 🍀 As we jump into another big week in #medtech, let's first run through a few highlights from last... MedTech Innovator kicked off their 2024 Pitch Event Road Tour in LA, an incredible opportunity for the #innovators and #entrepreneurs in our industry to pitch and potentially partner with the largest nonprofit accelerator in the world. Congratulations to all those that will move forward! Paul Grand Busy week for #surgicalrobotics as Intuitive won #FDA clearance for its next gen Davinci 5, their most advanced and integrated system yet, while SS Innovations announced its first #mitral valve replacement using their robot. CMR Surgical announced a first use case of their platform in #Sweden Supratim Bose Mark Slack Luke Hares Cosm Medical received clearance for its #pelvicfloor technology, making the first personalized pessary available Derek Sham #Diabetes was active this week as the International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) was held in Italy, Medtronic Diabetes, Dexcom, and Abbott all announcing positive progress. Centese made big strides in their their clinical trials for better #cardiacsurgery and #atrialfibrillation care Evan Luxon Randy Preston, while Abbott and Edwards Lifesciences continue their race in better #tavr technologies Autonomix Medical completed its first #RF #ablation trial to treat #pancreatic cancer pain, important mission Lori Bisson and team More buzz with #neuro as SetPoint Medical won an approval for the treatment of #MS, and Axonics, Inc. received a new #CEMark, and Sooma Medical raised $5.4 Mil for their depression #neuromodulation device Tuomas Neuvonen SafeGuard Surgical won a FDA Breakthrough nod for a #colorectal stent developed in #Tampa Fl Scott Kelley, MD Affluent Medical announced #FIH implant of their #urinaryincontinence device Sebastien Ladet, Ph.D. Finally, my favorite article of the week is interesting as the Total Product Lifecycle Advisory Program (TAP) within #FDA is new, and in particular helpful for innovation like #BCI technology and ONWARD Medical. This program requires Breakthrough Device Designation, and is assembled to provide earlier and more frequent engagement with company and agency, ideally streamlining the process. THANK YOU to all my newspartners LSI, MassDevice, MedTech Dive, FierceHealthcare, Sean Whooley, Tom Salemi, Chris Newmarker, Danielle Kirsh and friends everywhere who share stories. https://lnkd.in/e9WSbrYJ

🧬FluidAI Medical, a #SOPHIE recipient and postoperative medical technology company, recently invested $25 million in manufacturing its Origin™ medical device! 👉The team started their journey in 2014, with the goal to develop a postoperative monitoring solution to address post-surgery complications that can occur during recovery. “ Innovation Factory ’s Synapse Life Science Competition was actually a key moment for us. It was when we were going through a major pivot and a major transition in terms of product design,” added Abdelgawad. 🔬After pivoting and multiple iterations to their design, the team created what we now know as the Origin™, a non-invasive postoperative medical device that works in combination with the Stream™ Platform to analyze and accurately diagnose fluid samples. 🤝FluidAI's journey is a testament to how collaborations within the ecosystem can help set up entrepreneurs for success and growth in the sector. 💡How did FluidAI leverage the ecosystem and programs like SOPHIE and #HEALTHI to get to where they are today? Read the full story to find out! https://loom.ly/Xf3vzCQ ---------------------------------------------------------------------------------------- #MedTech #LifeSciences #Technology #Innovation #Ontario

Check out the latest report from IMIR Market Research Pvt. Ltd.  on the 𝗢𝗿𝘁𝗵𝗼𝗽𝗲𝗱𝗶𝗰 𝗡𝗮𝘃𝗶𝗴𝗮𝘁𝗶𝗼𝗻 𝗦𝘆𝘀𝘁𝗲𝗺𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 Outlook and Geography Forecast till 2028 Don't miss out on this opportunity to stay informed about the latest trends in the industry. Orthopedic Navigation Systems Market Size, Share & Trends Analysis Report By Application (Knee, Hip, Spine) By Technology (Electromagnetic, Optical, Others) By End-use (Hospitals, Ambulatory Surgical Centers (ASCs)), Global Economy Insights, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2023 - 2031 📚 𝐆𝐞𝐭 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐚𝐭 𝐝𝐢𝐬𝐜𝐨𝐮𝐧𝐭𝐞𝐝 𝐩𝐫𝐢𝐜𝐞:👇 https://lnkd.in/eV3PD4t6 📚𝐓𝐨𝐩 𝐌𝐨𝐫𝐞 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 𝐀𝐫𝐞::👇 Arthrex. BKK B. Braun Melsungen AG Brainlab CASCINATION ClaroNav. Corin Group DePuy Synthes. Exactech. GE HealthCare Globus Medical. Intellijoint Surgical Inc. Johnson & Johnson KARL STORZ Kinamed Inc. Medtronic MicroPort Scientific India Pvt. Ltd.. Samsung NeuroLogica NDI (Northern Digital Inc.) NuVasive Omni Surgical LP OrthAlign, Inc. Orthokey s.r.l. Pixee Medical Scopis Medical Siemens Healthineers Smith+Nephew Stereotaxis. Stryker Vuzix Corporation Zimmer Biomet

Patient Positioning Systems Market Size, Share & Trends Analysis Report By Product (Tables, Surgical Tables, Radiolucent Imaging Tables, Examination Tables, Accessories, Other Patient Positioning Systems) By Application (Surgeries, Disease Diagnosis, Cancer Therapy) By End User (Hospitals, Ambulatory Surgery Centers, Diagnostic Laboratories, Other End Users), Global Economy Insights, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2023 - 2031. Check out the latest report from 𝐈𝐧𝐭𝐞𝐥𝐥𝐞𝐜𝐭𝐮𝐚𝐥 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝟐𝟎𝟐𝟑-𝟐𝟎𝟑𝟏 Covers Various 𝐑𝐞𝐠𝐢𝐨𝐧𝐬 Including: #NorthAmerica #Europe #AsiaPacific #LatinAmerica #Africa. Don't miss out on this opportunity to stay informed about the latest trends in the Industry. 🌐𝐈𝐌𝐈𝐑 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐏𝐯𝐭. 𝐋𝐭𝐝. 𝐆𝐞𝐭 𝐭𝐡𝐞 𝐬𝐚𝐦𝐩𝐥𝐞 𝐫𝐞𝐩𝐨𝐫𝐭: https://lnkd.in/dXh_P3FD 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐰𝐨𝐫𝐤𝐢𝐧𝐠 𝐢𝐧 𝐭𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭: ALVO Medical Anetic Aid Ltd. Beaver Healthcare and Rehabilitation Center Transasia Bio-Medicals Ltd. Bristol Maid - Hospital Metalcraft Ltd CQ Medical Formerly CIVCO Radiotherapy C-RAD AB Dren Bio, Inc. Elekta Eschmann Technologies Ltd FAMED Żywiec Gendron Getinge @Graham-Field (GF Health Products, Inc) Inc. GPC Medical Ltd. Guangdong Meicen Medical Equipment Co., Ltd. Hillrom Innovative Medical Products Leoni Studer Hard AG Mediland Enterprise Corporation Medline Industries, LP Medtronic Merivaara Corp. Mizuho OSI Moore Medical NARANG MEDICAL LIMITED Oncology Systems Limited ONCOTECH Medical Systems OPT SurgiSystems Orfit ProBed Medical SchureMed Skytron Smith+Nephew STERIS Stryker The Brewer-Garrett Company Xodus Medical #positioning #branding #marketing #business #brandpositioning #digitalmarketing #brandstrategy #marketingstrategy #socialmediamarketing #socialmedia #brand #g #starreviews #strategy #design #brandingstrategy #communication #advertising #onlinemarketing #brandidentity #reputation #websitetraffic #remarketing #contentisking #reputationmanagement #retargeting #internetsolutions #reputationmarketing #onlinelocalvideo #reviews

📢Pulse Biosciences, Inc. secures FDA approval for CellFX nsPFA system CellFX is a percutaneous electrode system intended for use in the ablation of soft tissue in percutaneous and intraoperative surgical procedures. The system is designed to deliver nanosecond pulses of electrical energy to non-thermally clear cells, without affecting adjacent noncellular tissue. It comes with a percutaneous needle electrode, used with CellFX nsPFA Console, to deliver the advantages of nsPFA energy, enabling precise, non-thermal removal of cellular tissue. The electrode is designed to induce thermal necrosis, without damaging noncellular structures, and is not recommended for non-cardiac applications. Pulse Biosciences, Inc. president and CEO Kevin Danahy said: “The FDA clearance of our Percutaneous Electrode System is the initial major milestone for Pulse Biosciences in surgery. “It opens a new set of clinical applications and opportunities wherein our proprietary, one-of-a-kind, patented CellFX nsPFA technology is highly differentiated and holds the potential to change the present time standard of care. “I couldn’t be more proud of the engineering, clinical and regulatory teams at Pulse Biosciences for their commitment to bringing the safety and effectiveness benefits of nsPFA to our physician, caretaker and patient partners. “Internally, our team is pleased with its manufacturing and operational readiness as we initiate our training and commercialization programs in the coming weeks.” Read more online: https://lnkd.in/ePX-MU7D 📰 Follow Medical Device Developments to receive the latest medical device news daily and to subscribe to our weekly newsletter #MedicalDeviceDevelopments #pulsebiosciences #ablation

☑️ Insilico Medicine launches an AI assistant to aid in drafting medical research papers, designed to assist rather than instantly generate content. ☑️ Asensus Surgical wins FDA 510(k) clearance for the use of its surgical robot in urology, expanding its indications. ☑️ Volta Medical and GE HealthCare enter a joint development agreement for AI-driven electrophysiology technology. ☑️ FDA clears Tulavi Therapeutics's surgical hydrogel nerve cap, designed to prevent phantom limb pain in amputees by stopping neuroma growth. ☑️ Truvian raises $74M to bring a blood test instrument to market, aiming to perform commonly ordered blood tests without central lab involvement. #InsightswithSmarteeva #Medtech #complaintmanagement #Pharma #Smarteeva #biotech #medtechtrends #medtechindustry #medicaltechnology #technology #health #medicaldevicediagnostics #ai #mdr #recalls #complaints #mir #fda #cvr

The global 𝐄𝐥𝐞𝐜𝐭𝐫𝐨𝐬𝐮𝐫𝐠𝐞𝐫𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 in terms of revenue was estimated to be worth $6.9 billion in 2024 and is poised to reach $9.4 billion by 2029, growing at a CAGR of 6.4% from 2024 to 2029. 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐭𝐡𝐞 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 𝐚𝐭 https://lnkd.in/di_trFCS Recent Developments of Electrosurgery Industry: - In April 2024, Integra LifeSciences Holdings Corporation (US) has acquired Acclarent, Inc. (US), one of the leading companies in ENT surgical solutions. This strategic move broadens Integra's product range, enhances market presence, and unlocks a USD 1 billion growth opportunity in the ENT device sector. - In March 2024, Medical Device Business Services a subsidiary of Johnson & Johnson (US) collaborated with NVIDIA Corporation (US). This collaboration aims to enhance real-time analysis and make AI algorithms more widely accessible in operating rooms at global level. By leveraging AI, surgeons can make informed decisions, improve education, and foster collaboration within connected ORs, ultimately enhancing patient outcomes. 𝐓𝐨𝐩 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬: Medtronic Medtronic CEMA Johnson & Johnson Olympus Corporation Olympus APAC CONMED Corporation B. Braun Melsungen AG Vascular Systems Boston Scientific Smith+Nephew Erbe Elektromedizin GmbH Stryker BOWA-electronic KG THE COOPER COMPANIES GLOBAL HOLDINGS LP Kirwan Surgical Products LLC Zimmer Biomet Utah Medical Products, Inc. Integra LifeSciences Holdings SAS Encision KLS Martin Group - IPS KLS Martin Group Surgical Holdings I.C. Medical Meyer-Haake GmbH - Medical Innovations Aspen Surgical Applied Medical RESOURCES CORPORATION Apyx Medical Epmd Biomedical GROUP DirectaDentalGroup

🫀🤝More and more activity in the #structuralheart arena as Edwards Lifesciences continues their aggressive M&A streak with a $300M acquisition of Israeli based #mitralvalve start-up, Innovalve Bio Medical Ltd. This news comes right off the heels of last week’s $16.5M strategic partnership with France based mitral valve start-up Affluent Medical toward their Kephalios annuloplasty and biometric analysis technology. Innovalve Bio Medical Ltd. just recently received FDA permission to begin US human feasibility studies toward their Innostay transcathater based mitral valve replacement implant. “Building on our learnings of the complexity of mitral disease, we know there is a need for a differentiated range of therapies for these patients. Edwards’ SAPIEN M3 remains on track to become the first approved transfemoral TMVR system in Europe by the end of 2025. We believe the Innovalve technologies, paired with Edwards’ deep mitral expertise, will enable a TMVR platform that will expand the treatable population.” - Daveen Chopra, Edwards Lifesciences Transcatheter Mitral & Tricuspid Therapy Group Leader

𝗣𝗲𝗿𝗶𝗽𝗵𝗲𝗿𝗮𝗹 𝗩𝗮𝘀𝗰𝘂𝗹𝗮𝗿 𝗗𝗲𝘃𝗶𝗰𝗲𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 𝟮𝟬𝟮𝟰-𝟮𝟬𝟯𝟭. 𝗚𝗹𝗼𝗯𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗥𝗲𝗽𝗼𝗿𝘁 The research report offers a comprehensive overview of the Peripheral Vascular Devices industry chain, detailing the market status of treatments for both peripheral blood vessel damage and blockage, including Peripheral Vascular Stents and PTA Balloon Catheters. It highlights key enterprises operating in developed and developing markets and analyzes cutting-edge technology, patents, applications, and trends within the Peripheral Vascular Devices sector. Regionally, the report examines the Peripheral Vascular Devices markets in North America, Europe, and Asia-Pacific, noting steady growth in North America and Europe driven by government initiatives and increasing consumer awareness. Meanwhile, Asia-Pacific, particularly China, leads the global market, supported by robust domestic demand, favorable policies, and a strong manufacturing base. The market is segmented by Type and Application, with accurate forecasts provided for consumption value by Type and Application in terms of both volume and value for the 2024-2031 period. 𝗧𝗼 𝗞𝗻𝗼𝘄 𝗚𝗹𝗼𝗯𝗮𝗹 𝗦𝗰𝗼𝗽𝗲 𝗮𝗻𝗱 𝗗𝗲𝗺𝗮𝗻𝗱 𝗼𝗳 𝗣𝗲𝗿𝗶𝗽𝗵𝗲𝗿𝗮𝗹 𝗩𝗮𝘀𝗰𝘂𝗹𝗮𝗿 𝗗𝗲𝘃𝗶𝗰𝗲𝘀 𝗠𝗮𝗿𝗸𝗲𝘁. 𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗳𝗼𝗿 𝗦𝗮𝗺𝗽𝗹𝗲 𝗣𝗗𝗙: https://lnkd.in/eM_P6tTk *𝗕𝘆 𝗧𝘆𝗽𝗲: Peripheral Vascular Stents, PTA Balloon Catheter, Embolic Protection Device, Aortic Stent Graft, Surgical Artificial Transplant *𝗕𝘆 𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻: The Treatment Of Peripheral Blood Vessels Damaged, The Treatment Of Peripheral Blood Vessels Blockage *𝗕𝘆 𝗥𝗲𝗴𝗶𝗼𝗻: North America, Europe, Asia-Pacific, South America, Middle East & Africa *𝗕𝘆 𝗞𝗲𝘆 𝗣𝗹𝗮𝘆𝗲𝗿𝘀: Medtronic, Angiomed GmbH, Abbott, Terumo Medical Corporation, Endologix LLC, Bolton Medical, , Aesculap (US), Boston Scientific, Lepu Medical Technology (Beijing) Co., Ltd., MicroPort, Bioteque Corporation #peripheralvasculardevices #vascularsurgery #medicaldevices #healthcare #cardiology #interventionalmedicine #research #innovation #linkedin #linkedinprofile #linkedinconnect #medicaltechnology #linkedinpost #linkedinmarketing #linkedinnetworking #linkedincommunity #patientcare #clinicalpractice #medicalresearch

Recent Investments in the #LeftVentricularAssistDevice (LVAD) Market: Key Updates: Abiomed, has invested heavily in R&D, developing next-gen LVAD systems with advanced automation and AI-powered monitoring. In Q2 2024, they announced a $50M investment in their latest HeartMate III clinical trials. Abbott, through its Thoratec division, expanded its product pipeline with an additional $30M investment in its HeartMate LVAD line. The HeartMate 3 has emerged as a market leader, focusing on BTT (Bridge-to-Transplant) and DT (Destination Therapy) applications. Medtronic, after acquiring HeartWare, committed an additional $60M towards refining the miniaturized LVAD systems. Their ongoing clinical trials for HeartWare HVAD are expected to enhance its positioning in DT therapies. Berlin Heart GmbH, with a focus on pediatric patients, secured $25M in new funding to scale their EXCOR LVAD technology. This investment will help expand global reach in pediatric heart failure treatments. Jarvik Heart, Inc., recently announced an infusion of $20M for product innovation in their Jarvik 2000 device. This will enhance the long-term reliability and scalability of LVADs in both BTT and DT segments. Sun Medical Technology Research Corp., has been heavily investing in R&D for new LVAD systems with an expected $15M funding for the development of biocompatible devices. ReliantHeart Inc., with a focus on remote monitoring, has secured $18M in venture capital funding aimed at enhancing connectivity and real-time monitoring features in their HeartAssist5 devices, bolstering their BTT therapy applications. Read Report @ https://lnkd.in/gSFpdMuQ #HealthcareTrends #MedTech #CardiacCare #HeartFailureTreatment #LVADResearch #MedicalDevices #HealthInnovation #HealthcareTechnology #InvestmentInHealthcare #Cardiology #HeartHealth #BTTTherapy #DestinationTherapy #HealthData #DigitalHealth #HeartSurgery #MedicalResearch #LVADAdvancements #ClinicalResearch #CardiovascularHealth #MedicalInnovation #LeftVentricularAssistDevice #LVADMarket #LVADTrends #LVADTechnology #HeartTransplant #VentricularAssistDevice #LVADInvestments #CardiacDevices #VentricularSupport #LVADTherapies #LVADMarketResearch #LVADGrowth #HeartFailureTherapies #LVADClinicalTrials #LVADIndustry #CardiologyMarket #LVADTechnologyInnovation #LVADDevices #HeartSupportMarket #LVADProductDevelopment